Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 2529 entries
View as:

Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02064868 Org: User:
Start: 01/31/14 End: 04/25/17 Due: 04/25/18

A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00931762 Org: User:
Start: 08/31/09 End: 08/29/11 Due: 08/29/12

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00826371 Org: User:
Start: 01/31/09 End: - Due: -

A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.

Phase: N/A Priority: Normal
NCT ID: NCT02601378 Org: User:
Start: 02/01/16 End: 01/07/22 Due: 01/07/23

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT04895202 Org: User:
Start: 11/19/21 End: 12/20/22 Due: 12/20/23

Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT02268526 Org: User:
Start: 06/02/15 End: 12/07/16 Due: 12/07/17

Safety and Efficacy of DNK333 in Atopic Dermatitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01033097 Org: User:
Start: 11/30/09 End: 07/31/11 Due: 07/31/12

A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.

Phase: N/A Priority: Normal
NCT ID: NCT00390858 Org: User:
Start: 09/30/03 End: 02/29/08 Due: 02/28/09

Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease

Phase: N/A Priority: Normal
NCT ID: NCT04540861 Org: User:
Start: - End: - Due: -

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00853658 Org: User:
Start: 03/31/09 End: 10/31/15 Due: 10/31/16

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00109707 Org: User:
Start: 04/30/05 End: 09/30/12 Due: 09/30/13

Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)

Phase: N/A Priority: Normal
NCT ID: NCT02014636 Org: User:
Start: 12/27/13 End: 02/27/19 Due: 02/27/20

A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.

Phase: N/A Priority: Normal
NCT ID: NCT03809611 Org: User:
Start: 04/26/19 End: 12/16/19 Due: 12/16/20

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00941798 Org: User:
Start: 07/31/09 End: 05/31/11 Due: 05/31/12

Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02566044 Org: User:
Start: 09/27/17 End: 04/24/18 Due: 04/24/19

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Phase: N/A Priority: Normal
NCT ID: NCT00601978 Org: User:
Start: 08/31/08 End: 11/30/09 Due: 11/30/10

Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02044848 Org: User:
Start: 02/28/14 End: 09/30/14 Due: 09/30/15

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism

Phase: N/A Priority: Normal
NCT ID: NCT03938454 Org: User:
Start: 10/16/19 End: 11/29/23 Due: 11/29/24

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT00260208 Org: User:
Start: 01/31/06 End: - Due: -

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02468193 Org: User:
Start: 09/24/15 End: 10/29/18 Due: 10/29/19

Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT05893836 Org: User:
Start: 04/27/21 End: 06/30/21 Due: 06/30/22

Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00108836 Org: User:
Start: 03/31/05 End: 05/31/06 Due: 05/31/07

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00809614 Org: User:
Start: 03/31/09 End: 12/31/10 Due: 12/31/11

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00621244 Org: User:
Start: 03/01/03 End: 12/03/09 Due: 12/03/10

Canakinumab MAP in COVID-19 Pneumonia With CRS

Phase: N/A Priority: Normal
NCT ID: NCT04476706 Org: User:
Start: - End: - Due: -